General Updates

Biocon Limited has issued a communication to its shareholders detailing the deduction of Tax at Source (TDS) on the final dividend for the financial year 2025-26. The Board had recommended a final dividend of 10% (Re. 0.50 per equity share) on May 7, 2026, which is subject to shareholder approval at the AGM on August 6, 2026, with July 3, 2026, as the record date. The notice outlines the applicable TDS provisions, varying rates based on shareholder categories and residential status, and requests shareholders to update their PAN and other relevant details to ensure correct tax deduction or exemption.